The BACE1 mediated cleavage of InsRβ releases InsR from the cell membrane, which would interfere with the insulin-signaling pathway, and a clinical cohort study shows elevated plasma BACE1 level and enzyme activity of individuals with T2DM [18]. This evidence concerns the gene INS and type 2 diabetes mellitus.